Product Information
NORETHIN-ETH ESTRAD 1 MG-5 MCG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5799 per EA under NDC 68462065729. Its NADAC has been published 585 times since Jul 22, 2015.
FDA first approved this application on Apr 2, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 1 ug/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462065729
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA203038FDA Approved
4/2/2015
TE Code
AB
On Market Since
4/2/2015
Price Statistics
The NADAC for NORETHIN-ETH ESTRAD 1 MG-5 MCG has been published 585 times since Jul 22, 2015, and over the history we have for it it has declined 75.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5799 per EA |
|---|---|
| All-time high | $2.3891 (Aug 12, 2015) |
| All-time low | $0.5602 (Aug 19, 2026) |
| 52-week high | $1.1010 |
| 52-week low | $0.5602 |
| Median price | $1.3017 |
| Average price | $1.4177 |
| Largest weekly change | +78.4% (Jun 19, 2024) |
| Weeks tracked | 585 |
| Tracking since | Jul 22, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORETHIN-ETH ESTRAD 1 MG-5 MCG?
The current National Average Drug Acquisition Cost (NADAC) for NORETHIN-ETH ESTRAD 1 MG-5 MCG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5799 per EA (NDC 68462065729), effective Sep 30, 2026.
How has the price of NORETHIN-ETH ESTRAD 1 MG-5 MCG changed over time?
Over the history we have for it, the NADAC for NORETHIN-ETH ESTRAD 1 MG-5 MCG has declined 75.7%. It has been tracked across 585 weekly CMS publications since Jul 22, 2015.
What are the highest and lowest recorded NADAC prices for NORETHIN-ETH ESTRAD 1 MG-5 MCG?
Since Jul 22, 2015, the NADAC for NORETHIN-ETH ESTRAD 1 MG-5 MCG has ranged from a low of $0.5602 (Aug 19, 2026) to a high of $2.3891 (Aug 12, 2015), with a median of $1.3017 per EA.
Are there cheaper alternatives to NORETHIN-ETH ESTRAD 1 MG-5 MCG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NORETHIN-ETH ESTRAD 1 MG-5 MCG in a comparable dosage form, but none are currently priced below it.
Who manufactures NORETHIN-ETH ESTRAD 1 MG-5 MCG?
NORETHIN-ETH ESTRAD 1 MG-5 MCG (NDC 68462065729) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.